These effects, along with a previous report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two assist the thought of targeting ACKR3 as a unique strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-related Ailment